Galectin Therapeutics Inc. (GALT)

Galectin Therapeutics Statistics

Total Valuation

GALT has a market cap or net worth of $291.47 million. The enterprise value is $399.75 million.

Market Cap	291.47M
Enterprise Value	399.75M

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

GALT has 64.06 million shares outstanding. The number of shares has increased by 2.40% in one year.

Current Share Class	64.06M
Shares Outstanding	64.06M
Shares Change (YoY)	+2.40%
Shares Change (QoQ)	+0.38%
Owned by Insiders (%)	20.53%
Owned by Institutions (%)	17.28%
Float	44.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.43

Current Ratio	1.43
Quick Ratio	1.28
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.01

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-98.30%
Return on Invested Capital (ROIC)	-262.50%
Return on Capital Employed (ROCE)	-704.56%
Revenue Per Employee	n/a
Profits Per Employee	-$2.70M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +73.00% in the last 52 weeks. The beta is 0.87, so GALT's price volatility has been lower than the market average.

Beta (5Y)	0.87
52-Week Price Change	+73.00%
50-Day Moving Average	4.06
200-Day Moving Average	2.17
Relative Strength Index (RSI)	51.01
Average Volume (20 Days)	360,403

Short Selling Information

The latest short interest is 8.05 million, so 12.56% of the outstanding shares have been sold short.

Short Interest	8.05M
Short Previous Month	7.99M
Short % of Shares Out	12.56%
Short % of Float	17.89%
Short Ratio (days to cover)	23.47

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-34.02M
Pretax Income	-40.34M
Net Income	-40.46M
EBITDA	n/a
EBIT	-34.02M
Earnings Per Share (EPS)	-$0.64

Balance Sheet

The company has $13.77 million in cash and $122.05 million in debt, giving a net cash position of -$108.28 million or -$1.69 per share.

Cash & Cash Equivalents	13.77M
Total Debt	122.05M
Net Cash	-108.28M
Net Cash Per Share	-$1.69
Equity (Book Value)	-117.17M
Book Value Per Share	-1.86
Working Capital	4.65M

Cash Flow

Operating Cash Flow	-35.62M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GALT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.40%
Shareholder Yield	-2.40%
Earnings Yield	-13.88%
FCF Yield	n/a

Analyst Forecast

The average price target for GALT is $6.00, which is 31.87% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	31.87%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 23, 2012. It was a reverse split with a ratio of 1:6.

Last Split Date	Mar 23, 2012
Split Type	Reverse
Split Ratio	1:6

Scores

Altman Z-Score	n/a
Piotroski F-Score	1